Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

Featured Releases

December 19, 2025 08:42 ET | Source: Toobit

Toobit Celebrates the Holidays with $1M Christmas Trading Showdown

GEORGE TOWN, Cayman Islands, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Toobit, the award-winning global cryptocurrency exchange, today announces the launch of the Christmas Trading Showdown, a holiday...
Read More
December 19, 2025 08:30 ET | Source: GXO Logistics

GXO Appoints Karen Bomber as Chief Commercial Officer

Global role to accelerate expansion in high-growth segments, verticals and geographies GREENWICH, Conn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest...
Read More

December 19, 2025 08:48 ET | Source: ZenaTech Inc.

ZenaTech anuncia la apertura en el primer trimestre de 2026 del Centro de I+D Zena AI en Baton Rouge, para apoyar iniciativas de defensa de EE. UU., DARPA, IA federal y computación cuántica

VANCOUVER, Columbia Británica, Dec. 19, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas empresariales...
December 19, 2025 08:47 ET | Source: E Split Corp.

E Split Corp. Class A and Preferred Distributions

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- E Split Corp. (TSX: ENS and ENS.PR.A) (the “Fund”) is pleased to announce that a distribution for December 2025 will be payable to Class A shareholders as...
December 19, 2025 08:45 ET | Source: Newcap Holdings

Supplerende oplysninger om forslag til udstedelse af nye aktier på ekstraordinær generalforsamling 30. december 2025

Selskabsmeddelelse nr. 15 / 2025 19. december 2025 Supplerende oplysninger om forslag til udstedelse af nye aktier på ekstraordinær generalforsamling 30. december 2025 For at give selskabets...
December 19, 2025 08:45 ET | Source: The Lovesac Company

The Lovesac Company Publishes 2025 ESG Report

STAMFORD, Conn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand, has released its ESG & Impact...
December 19, 2025 08:45 ET | Source: Amplia Therapuetics Limited

Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors

HIGHLIGHTS The preclinical research collaboration with specialist drug screening company Next & Bio has been extendedThe collaboration explores the effect of Amplia’s FAK inhibitors in...
December 19, 2025 08:45 ET | Source: Profound Medical Corp.

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of...
December 19, 2025 08:45 ET | Source: SEALSQ

SEALSQ Unveils Strategic Plan for 2026-2030 to Develop Silicon-Based Quantum Computing Using CMOS-Compatible Semiconductor Technologies

Geneva, Switzerland, Dec. 19, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum...
December 19, 2025 08:45 ET | Source: MediPharm Labs Corp.

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience

Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs
December 19, 2025 08:44 ET | Source: VERSES AI Inc.

VERSES Closes CAD$2.65 Million Convertible Debenture Unit Financing

VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company pioneering next-generation...
December 19, 2025 08:43 ET | Source: State Street International (Ireland) Limited

Form 8.3 - Avadel Pharmaceuticals plc

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

1 2 ...315113